Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa.
OBJECTIVES: To evaluate virologic response up to 48 weeks, and emergence of HIV-1 resistance mutations at 24 weeks, in therapy-naive adults initiating zidovudine/lamivudine/tenofovir DF. DESIGN: : A cohort within the DART trial. METHODS: Plasma HIV-1 RNA was assayed in 300 adults with baseline CD4 c...
| Үндсэн зохиолч: | |
|---|---|
| Формат: | Journal article |
| Хэл сонгох: | English |
| Хэвлэсэн: |
2006
|